Oruka Therapeutics Seeks $1.25B Capital Boost Through Shelf Registrations and $200M Equity Offering

Oruka Therapeutics has filed two shelf registrations totaling $1.25 billion and announced a $200 million follow-on equity offering. This suggests a strong effort to increase financial flexibility, which can influence investors' views on the company's ability to fund development and operations. While the new capital may address funding concerns, it also brings attention to cash management and dilution risks.